In this method for simultaneously determining hypoxanthine, xanthine, urate, and creatinine in cerebrospinal fluid, centrifuged sample is directly injected on a reversed-phase liquidchromatographic column. On elution with potassium phosphate buffer the compounds are quantified by their absorbance at 260 nm. Random error (CV) was between 1.2 and 3.4% and analytical recoveries were 99-i 04% at physiological concentrations. (6) indicates that xanthine rather than urate is the end product of brain purine metabolism. An initial observation of a concentration gradient across the blood-brain barrier for hypoxanthine and xanthine with the higher values in the CSF (Niklasson, unpublished) opened up the possibility that the CSF concentrations of these purines reflect the intrathecal purine metabolism rather than the blood concentration. I wished to investigate this thoroughly in patients suffering from certain pathological conditions of the central nervous system, and also to evaluate the potential diagnostic and prognostic value of measuring purine compounds in CSF. To do so, I developed the present HPLC method. It is accurate, precise and sensitive enough to detect even subnormal concentrations of hypoxanthine, xanthine, urate, and creatinine in the same isocratic run. Furthermore, no specimen pretreatment is needed, except for centrif)igation.
The eluent, potassium phosphate buffer (0.2 mollL, pH 6.6), was ultrafiltered and degassed by shaking it under reduced pressure before use. The chromatograph was operated isocratically at ambient temperature, with a flow rate of 1.0 mL/min. The absorbance at 260 nm was monitored and the sensitivity setting was usually 0.01 A full scale.
Procedures

Specimen handling. Measured
volumes of CSF were obtained by lumbar puncture, and an aliquot of each specimen was centrth.iged, decanted, and stored frozen at -20 or -70 #{176}C until analysis. Before analysis, the specimens were thawed at about 20#{176}C in a waterbath, then kept in an ice bath until injected. Minor erythrocyte contamination did not affect the results if the intact cells could be removed by centrifligation. If hemolysis occurred, hypoxanthine increased, being the main degradation product of purines in erythrocytes.
Calibration standards and calculations.
Four working standards were prepared by appropriate mixing and serial dilution of stock standard solutions, each containing 1.00 mmo]JL (in distilled water for creatinine and in 10 mmol/L NaOH for the others), to cover the following concentration ranges: 12.5-100 pmoI/L for creatinine, 6.25-50 moI/L for urate, and 0.625-10 mol!L for hypoxanthine and xanthine. The working standards were stored in 1-mL portions at -20 #{176}C. A new set of working standards was thawed on each analytical occasion and kept in the ice-bath until injected. The concentrations were calculated from the regression lines of the standards' peak heights vs concentrations, by using a minicalculator.
Identification. Hypoxanthine, xanthine, urate, and creatinine in CSF were identified by comparing their retention with the retention of pure standards and by their degradation on addition of enzymes.
To do this, I added 1 L of undiluted xanthine oxidase solution and (or) uricase solution to 200 pL of CSF for 10 mm at 22 #{176}C before injection. and about 20 pg each of ATP, phosphoenolpyruvate, and magnesium chloride. The reaction was allowed to proceed for 20 mm at 22 #{176}C, after which 20 L of the reaction mixture was injected on the HPLC column.
Imprecision and recovery.
Within-day imprecision was tested by dividing one CSF specimen into 0.5-mL portions in eleven tubes and making one injection from each of the tubes during the day. Day-to-day imprecision was calculated by analyzing a solution of known concentrations on 25 occasions during a period of three months. In the recovery experiment, 20 1L of a standard solution was added to 80-pL aliquots of seven different CSF specimens. The standard solution contained hypoxanthine and xanthine 20 moI/L each, urate 50 imolJL, and creatinine 100 mol/L. The specimens were analyzed before and after the addition.
Results
Figure 1 illustrates
four typical HPLC chromatograms obtained by the present method. The separation of pure standards is shown in la and the elution pattern of some components in CSF in lb. The result of enzymatic degradation of hypoxanthine and xanthine by xanthine oxidase is presented in lc. Finally, the elimination of the urate peak on addition of uricase is clear in ld. Creatinine was degraded in a similar way after addition of the proper enzymes.
The retention of each analyte was influenced by the pH of the eluent (Figure 2 ). Optimal separation of the actual analytes from other compounds present in CSF was at pH 6.6.
Hypoxanthine, xanthine, urate, and creatinine have absorbance maxima at 250, 270, 293, and 236 nm, respectively, at pH 6.6. Monitoring absorbance at 260 nm is thus not optimal for any of the analytes. However, owing to their presence in different concentrations in CSF, all four could be detected without changing attenuation during most of the runs. This means that the sensitivity of the method for the respective analytes can be increased by simply changing the wavelength of the detector.
Data on imprecision and recovery are presented in Tables  1 and 2 . The limits of detection, defined as twofold the baseline noise, were 3.2 pmol (0.16 molJL)
for hypoxanthine and xanthine, 3.9 pmol (0.2 mol/L) for urate, and 7.8 pmol (0.39 jimol/L) for creatinine (injection volume 20 ML).
Standard curves were linear for all four substances within the range tested, i.e., up to 50 p,mol/L for hypoxanthine and xanthine and 100 1mol/L for urate and creatinine.
Discussion
Specimens of biological origin usually have to be deproteinized before injection onto HPLC columns, precipitation and ultrafiltration being the methods most commonly used for this (9) . Because CSF can be regarded as an "ultrafiltrate of plasma" (protein content normally <0.5 g/L), it was tempting to see if the CSF could be injected onto the column directly after centrifugation. Such a technique in fact allows separation of several purine metabolites and creatinine on reversed-phase HPLC columns. Given the absence of any cumbersome specimen-pretreatment procedure, no internal standard was needed to obtain good precision and accuracy. It should, however, be possible to improve the precision further by using an electronic integrator to measure peak area, owing to the difficulty of measuring peak heights with less error than ±0.5 mm. This would correspond to variations of 2.5-1.6% when peak heights are 20-30 mm, which often is typical for hypoxanthine and xanthine. The differences in retention for the four analytes, when the pH of the eluent was changed, were due to their different dissociation constants (pKa). The plC0 of hypoxanthine is We have recently reported reference values for hypoxanthine, xanthine, and urate in CSF (11 Themethod presented here is superior to methods that do not allow separate estimations of hypoxanthine and xanthine concentrations (4) and also to other HPLC methods designed for only one of the oxypurines (16) ; valuable information about the pathophysiological mechanisms in several disorders of the central nervous system will be provided by assaying both. My coworkers and I have so far been able to demonstrate correlations between CSF oxypurines and certain symptoms in depressed patients (13) ; correlations of CSF oxypurines and the CSF monoamine metabolites 5-hydroxyindoleacetic acid and homovanillic acid (17) , and disturbances of the intrathecal purine metabolism due to hypoxia in cardiovascular disorders (11) . Hypoxanthine concentrations in CSF reportedly are increased in bacterial meningitis (16 
